Clinical significance of allelic loss of chromosome region 5q22.3∼q23.2 in nonpapillary renal cell carcinoma

Cancer Genetics and Cytogenetics

Volumn 136, Issue 1, 2002, Pages 23-30

  Nagao, Kazuhiro ^a   Yoshihiro, Satoru ^a   Matsuyama, Hideyasu ^a   Yamaguchi, Shiro ^a   Oba, Kazuo ^b   Naito, Katsusuke ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Masuda Red Cross Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANEUSOMY; ARTICLE; CHROMOSOME 5Q; CHROMOSOME ABERRATION; CHROMOSOME GAIN; CHROMOSOME LOSS; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOGENETICS; DISOMY; DNA PROBE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE FREQUENCY; HUMAN; HUMAN TISSUE; INTERPHASE; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; CHROMOSOME ABERRATIONS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 5; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KIDNEY NEOPLASMS; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; NEOPLASM STAGING;

EID: 0036649110     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(02)00511-3     Document Type: Article

References (42)

1. Morphological clssification of renal cancer
2. Epidemiology of kidney cancer
3. Deletion mapping in human renal cell carcinoma
4. Allelic deletions in renal tumors: Histopathological correlations
5. Molecular cytogenetics of renal cell tumors
6. Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology
7. Diagnosis and prognosis of renal-cell tumors: A molecular approach
8. Clonal chromosome abnormalities in tumor cells from patients with sporadic renal cell carcinomas
9. Cytogenetics of renal cellcarcinomas associated with von Hippel-Lindau disease
10. Common regions of deletion on chromosome 5q, 6q, and 10q in renal cell carcinoma
11. Genetic alterations in sporadic renal-cell carcinoma: Molecular analyses of tumor suppressor gene harboring chromosomal regions 3p, 5q, and 17p
12. Molecular genetic investigation of sporadic renal cell carcinoma: Analysis of allele loss on chromosomes 3p, 5q, 11p, 17 and 22
13. Comprehensive allelotyping of human renal cell carcinomas using microsatellite DNA probes
14. Detection of loss of heterozygosity in the APC tumor suppressor gene in nonpapillary renal cell carcinoma by microdissection and polymerase chain reaction
15. Duplication of an approximately 1.5 Mb DNA segment at chromosome 5q22 indicates the locus of a new tumor gene in nonpapillary renal cell carcinomas
16. Renal cell carcinoma genetic analysis by comparative genetic hybridization and restriction fragment length polymorphism analysis
17. Genetics as diagnostic tool in sarcomatoid renal-cell cancer
18. Cytogenetic analysis of epithelial renal-cell tumors: Relationship with a new histopathological classification
19. Kidney (ICD-O C64)
20. Analysis of numerical aberrations in specific chromosomes by fluorescent in situ hybridization as a diagnostic tool in breast cancer
21. Delineation of individual human chromosomes in metaphase and interphase cells by in situ suppression hybridization using recombinant DNA libraries
22. Deletion mapping of chromosome 8p in prostate cancer by fluorescence in situ hybridization
23. Two putative tumor suppressor genes on chromosome arm 8p may play different roles in prostate cancer
24. C-myc copy number gains in bladder cancer detected by fluorescence in situ hybridization
25. A detailed deletion mapping of the short arm of chromosome 3 in sporadic renal cell carcinoma
26. Common regions of deletion in chromosome regions 3p12 and 3p14.2 in primary clear cell renal carcinomas
27. Identification of the von Hippel-Lindau disease tumor suppressor gene
28. Mutation of the VHL tumor suppressor gene in renal carcinoma
29. Mutation of the VHL gene is associated exclusively with the development of non-papillary renal cell carcinomas
30. Genetic aberrations detected by comparative genomic hybridization are associated with clinical outcome in renal cell carcinoma
31. Molecular cytogenetic analysis of 17 renal cancer cell lines: Increased copy number at 5q31-33 in cell lines from nonpapillary carcinomas
32. Duplication of two distinct regions on chromosome 5q in non-papillary renal-cell carcinomas
33. Identification and characterization of familial adenomatous polyposis coli gene
34. Identification of a gene located at chromosome 5q21 that is mutated in colorectal cancers
35. Mutation of chromosome 5q21 genes in FAP and colorectal cancer patients
36. Allelotype study of primary hepatocellular carcinoma
37. Loss of heterozygosity involving the majority of human esophageal cancers
38. MCC, a candidate familialpolyposis gene in 5q.21, shows frequent allele loss in colorectal and lung cancer
39. A frequent deletion of chromosome 5q21 in advanced small cell and non-small cell carcinoma of the lung
40. Frequent somatic mutations of the APC gene in human pancreatic cancer
41. Independent value of tumor size and DNA ploidy for the prediction of disease progression in patients with organ-confined renal cell carcinoma